The Impact of PET/MRI Fusion on the Diagnostic Imaging Industry

被引:0
|
作者
Aldahery, Shrooq [1 ]
机构
[1] Univ Jeddah, Coll Appl Med Sci, Dept Appl Radiol Technol, Jeddah, Saudi Arabia
关键词
hybrid imaging; PET/MRI; technical challenges; dose advantage; 1ST CLINICAL-EXPERIENCE; F-18-FDG PET/CT; NEXT-GENERATION; HYBRID PET/MRI; MR; HEAD; PERFORMANCE; DESIGN; BRAIN; FEASIBILITY;
D O I
10.21103/Article13(3)_RA4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The multimodal imaging technique has gained the spotlight in the present era due to its striking and immense applications. It is the combination of two or more modalities that complement one another to yield detailed information. Indubitably, it is an emerging and crucial technique due to its broad clinical and research applications. The diagnostic techniques with the dual modality are aligned for obtaining molecular data. Positron emission tomography (PET) is a progressive imaging technique in nuclear medicine. To flourish in the imaging industry, PET was combined with computed tomography (CT), but the fusion of the two provides some challenges, such as less soft tissue contrast and inefficiency of acquisition in simultaneous mode. As a result, another hybrid imaging technology, PET and MRI (PET/MRI), has been developed to provide more soft tissue contrast and less radiation dose exposure, leading this technique to be used extensively despite its shortcomings. This review study discusses the fusion of PET/MRI, technical challenges for their combination, commercially available models, and clinical applications observed in the wide areas of oncology, the cardiovascular system, the central nervous system, pediatrics, and inflammatory diseases.(International Journal of Biomedicine. 2023;13(3):46-53.)
引用
收藏
页码:46 / 53
页数:8
相关论文
共 50 条
  • [1] THE IMPACT OF PET/CT FUSION IMAGING TECHNOLOGY IN CANCER: ADDITIONAL VALUE FOR DIAGNOSTIC IMAGING AND PATIENT MANAGEMENT
    Ghi, M. G.
    Mastromauro, C.
    Carnuccio, R.
    Cracco, E.
    Rossi, F. Dei
    Gravili, S.
    Biason, R.
    Medici, M.
    D'Amanzo, P.
    Paccagnella, A.
    ANNALS OF ONCOLOGY, 2004, 15 : 41 - 41
  • [2] PET/MRI FUSION
    Wheat, J.
    Currie, G.
    Trifunivic, M.
    Magnussen, J.
    Kiat, H.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 51 - 51
  • [3] Diagnostic Performance of Prone 18F-FDG PET/MRI Fusion Imaging for Breast Cancer: Comparison with Prone PET/contrast-enhanced CT and MRI
    Kataoka, Y.
    Nogami, M.
    Ohnishi, T.
    Kohsaki, S.
    Akagi, N.
    Hamada, N.
    Kubota, K.
    Nishioka, A.
    Ogawa, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S284 - S285
  • [4] Potential use of PET-MRI fusion imaging for brain diseases
    Son, Young Don
    BEHAVIOR GENETICS, 2010, 40 (06) : 813 - 813
  • [5] Added Diagnostic Confidence of FDG PET Imaging in Patients with Multiple Myeloma assessed by PET/MRI, PET/CT and Whole Body MRI
    Nardo, Lorenzo
    Facchetti, Luca
    Martin, Tom
    Wolf, Jeffrey
    Hope, Thomas
    Link, Thomas
    Pampaloni, Miguel Hernandez
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [6] Diagnostic accuracy in gynecological malignant tumors: A comparison between PET/CT and PET/MRI fusion images
    Nakajo, Kazuya
    Tatsumi, Mituaki
    Inoue, Atsuo
    Isohashi, Kayako
    Higuchi, Ichiro
    Kato, Hiroki
    Shimosegawa, Eku
    Hatazawa, Jun
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [7] In-vivo Human Molecular Imaging Using PET-MRI Fusion Imaging Technology
    Cho, Zang-Hee
    BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK, 2012, 57 : 1 - 1
  • [8] Oleanolic acid-conjugated nanoparticle for PET/MRI fusion imaging of tumor
    Yim, M.
    Ryu, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S406 - S406
  • [9] Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions
    Sergiu Scobioala
    Christopher Kittel
    Heidi Wolters
    Sebastian Huss
    Khaled Elsayad
    Robert Seifert
    Lars Stegger
    Matthias Weckesser
    Uwe Haverkamp
    Hans Theodor Eich
    Kambiz Rahbar
    Annals of Nuclear Medicine, 2021, 35 : 628 - 638
  • [10] Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions
    Scobioala, Sergiu
    Kittel, Christopher
    Wolters, Heidi
    Huss, Sebastian
    Elsayad, Khaled
    Seifert, Robert
    Stegger, Lars
    Weckesser, Matthias
    Haverkamp, Uwe
    Eich, Hans Theodor
    Rahbar, Kambiz
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (05) : 628 - 638